CoChat
Sign Up
Cited by 203Pharmacology and Obesity TreatmentCoffee research and impactsMedicinal Plants and Bioactive Compounds

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial

Boozer, CN, Daly, PA, Homel, P, Solomon, JL, Blanchard, D, Nasser, JA, Strauss, R, Meredith, T·2002·International Journal of Obesity
DOI 10.1038/sj.ijo.0802023
Open this paper in CoChat — free account

Abstract

Objective To examine long-term safety and efficacy for weight loss of an herbal Ma Huang and Kola nut supplement (90/192 mg/day ephedrine alkaloids/caffeine).Design Six-month randomized, double-blind placebo controlled trial.Subjects A total of 167 subjects (body mass index (BMI) 31.8+/-4.1 kg/m(2)) randomized to placebo (n=84) or herbal treatment (n=83) at two outpatient weight control research units.Measurements Primary outcome measurements were changes in blood pressure, heart function and body weight. Secondary variables included body composition and metabolic changes.Results By last observation carried forward analysis, herbal vs placebo treatment decreased body weight (-5.3+/-5.0 vs. -2.6+/-3.2 kg, P<0.001), body fat (-4.3+/-3.3 vs. -2.7+/-2.8 kg, P=0.020) and LDL-cholesterol (-8+/-20 vs. 0+/-17 mg/dl, P=0.013), and increased HDL-cholesterol (+2.7+/-5.7 vs. -0.3+/-6.7 mg/dl, P=0.004). Herbal treatment produced small changes in blood pressure variables (+3 to -5 mm Hg, P< or =0.05), and increased heart rate (4+/-9 vs. -3+/-9 bpm, P<0.001), but cardiac arrhythmias were not increased (P>0.05). By self-report, dry mouth (P<0.01), heartburn (P<0.05), and insomnia (P<0.01) were increased and diarrhea decreased (P<0.05). Irritability, nausea, chest pain and palpitations did not differ, nor did numbers of subjects who withdrew.Conclusions In this 6-month placebo-controlled trial, herbal ephedra/caffeine (90/192 mg/day) promoted body weight and body fat reduction and improved blood lipids without significant adverse events.

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.ijo.0802023

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 2

  1. Neergaard L . Since recent deaths, the FDA is studying dangers of ephedra Associated Press 17 April 2000.
  2. Kaats G, Adelman J, Blum K . Effects of a multiple herbal formulation on body composition, blood chemistry, vital signs, and self-reported energy levels & appetite control Int J Obes Relat Metab Disord 1994 18: S145.

Cited by

Sorted by citations

See all 203

Related

See all

Metadata

Authors
Boozer, C., Daly, P., Homel, P., Solomon, J., Blanchard, D., Nasser, J., Strauss, R., & Meredith, T.
Affiliations
  • St. Luke's-Roosevelt Hospital Center (US)
  • Beth Israel Deaconess Medical Center (US)
  • Mount Sinai Beth Israel (US)
  • Cigna (United States) (US)
  • World Health Organization (CH)
Corresponding author
Boozer, CN
Venue
International Journal of Obesity
Publisher
Springer Science and Business Media LLC
Published
2002-05
Volume
26
Issue
5
Pages
593-604
ISSN
  • 0307-0565 (ISSN-L)
  • 1476-5497
DOI
10.1038/sj.ijo.0802023
OpenAlex
W2120756383
Cited by
203
References
28
Citations by year
2026: 3 · 2025: 4 · 2024: 3 · 2023: 3 · 2022: 5 · 2021: 13 · 2020: 10 · 2019: 6 · 2018: 7 · 2017: 3 · 2016: 2 · 2015: 4 · 2014: 8 · 2013: 6 · 2012: 10
FWCI
12.71
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • International Journal of Obesity (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK-26687, P30DK026687)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
  • Health Sciences › Medicine › Pharmacology (medical) › Coffee research and impacts
  • Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Bioactive Compounds
Keywords
Ephedra, caffeine, Ma Huang, kola nut, herbal weight loss supplements, obesity, weight loss, fat mass, serum lipids, LDL cholesterol, HDL cholesterol, blood pressure, heart rate, cardiac arrhythmias, adverse events, xerostomia, heartburn, insomnia, long-term safety
MeSH terms
Blood Glucose, Blood Pressure, Body Composition, Body Weight, Caffeine, Cholesterol, Ephedrine, Heart Rate, Humans, Cholesterol, HDL, Cholesterol, LDL, Patient Compliance, Placebos, Prospective Studies, Triglycerides, Weight Loss, Electrocardiography, Ambulatory, Dietary Supplements, Plant Preparations, Ephedra, Ephedra sinica, Cola

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review